[10] [11] However, balance efficacy against gastrointestinal tolerability, as adverse effects may compromise adherence
Symptoms are usually moderate and disappear 8 days or less after they start
While semaglutide provides pharmacological appetite suppression, patients achieve optimal outcomes by combining medication with evidence-based lifestyle modifications
However, studies in animals have shown that semaglutide interacts with the circumventricular regions and specifically accesses GLP-1Rpositive brain regions following peripheral administration, including the area postrema in the hindbrain, the arcuate nucleus of the hypothalamus, and the lateral septal nucleus [50]
Individual response varies enormously based on body weight, metabolic factors, receptor sensitivity, and tolerance from prior medication use